Clinical Trial Update: MISC COVID-19 Study in Pediatric Population

View source ↗

Summary

A pediatric clinical trial update indicates a MIS-C and SARS-CoV-2 infection study is currently recruiting in India.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multisystem Inflammatory Syndrome in Children

Snippet

Sponsor: Tuberculosis Research Centre, India | Conditions: SARS-CoV2 Infection, Multisystem Inflammatory Syndrome in Children | Status: RECRUITING